PA
Parkwalk Advisors
Venture CapitalActiveParkwalk is an investment management firm focused on UK-based technology companies.
198
Investments
7
Exits
$1.5B
AUM
3.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Parkwalk Advisors.
Investment Thesis & Strategy
Parkwalk Advisors invests in various stages of UK-based technology companies, with a focus on fintech and venture capital. They seek to invest in innovative companies with high growth potential.
Investment Activity
Deals per year over the last 10 years
1
20140
20150
20160
20170
20182
20190
20201
20217
20221
2023Portfolio Companies
Selected investments from their portfolio of 198 companies
P
Presymptom Health
Healthcare · Series A, 2023
B
Baseimmune
Biotech · Series A, 2022
C
Cella Therapeutics
Biotech · Series A, 2022
P
Peptone
Biotech · Series A, 2022
P
Purespring Therapeutics
Biotech · Series A, 2022
A
Automata
Robotics · Series B, 2022
Q
Quantum Motion
Other · Series A, 2022
P
Phasecraft
Other · Series A, 2022
R
Riverlane
Other · Series A, 2021
F
First Light Fusion
Cleantech · Growth, 2019
O
Oxehealth
Healthcare · Series B, 2019
E
Exscientia
Biotech · Growth, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
BaseimmuneAcquisition2024—
CellaresAcquisition2024—
First Light FusionAcquisition2024—
VaccitechIPO2021$198M
Oxford Nanopore TechnologiesIPO2021$3.4B
ImmunocoreIPO2021$2.3B
Adaptimmune TherapeuticsIPO2015$200M
Frequently Asked Questions
Parkwalk Advisors focuses on Series A, Series B, Series C+ stage investments.